202 related articles for article (PubMed ID: 25029240)
1. Attenuation of immune-mediated influenza pneumonia by targeting the inducible co-stimulator (ICOS) molecule on T cells.
Sakthivel P; Gereke M; Breithaupt A; Fuchs D; Gigliotti L; Gruber AD; Dianzani U; Bruder D
PLoS One; 2014; 9(7):e100970. PubMed ID: 25029240
[TBL] [Abstract][Full Text] [Related]
2. ICOS
Nagase H; Takeoka T; Urakawa S; Morimoto-Okazawa A; Kawashima A; Iwahori K; Takiguchi S; Nishikawa H; Sato E; Sakaguchi S; Mori M; Doki Y; Wada H
Int J Cancer; 2017 Feb; 140(3):686-695. PubMed ID: 27756099
[TBL] [Abstract][Full Text] [Related]
3. ICOS-expressing lymphocytes promote resolution of CD8-mediated lung injury in a mouse model of lung rejection.
Wu Q; Gardiner GJ; Berry E; Wagner SR; Lu T; Clay BS; Moore TV; Ferreira CM; Williams JW; Luster AD; Medoff BD; Cannon JL; Sperling AI; Shilling RA
PLoS One; 2013; 8(8):e72955. PubMed ID: 23967339
[TBL] [Abstract][Full Text] [Related]
4. PD-1 and ICOS counter-regulate tissue resident regulatory T cell development and IL-10 production during flu.
McGee MC; Zhang T; Magazine N; Islam R; Carossino M; Huang W
Front Immunol; 2022; 13():984476. PubMed ID: 36159872
[TBL] [Abstract][Full Text] [Related]
5. Mesothelin virus-like particle immunization controls pancreatic cancer growth through CD8+ T cell induction and reduction in the frequency of CD4+ foxp3+ ICOS- regulatory T cells.
Zhang S; Yong LK; Li D; Cubas R; Chen C; Yao Q
PLoS One; 2013; 8(7):e68303. PubMed ID: 23874581
[TBL] [Abstract][Full Text] [Related]
6. Tumor-infiltrating mast cells stimulate ICOS
Lv Y; Tian W; Teng Y; Wang P; Zhao Y; Li Z; Tang S; Chen W; Xie R; Lü M; Zhuang Y
J Adv Res; 2024 Mar; 57():149-162. PubMed ID: 37086778
[TBL] [Abstract][Full Text] [Related]
7. Inducible Costimulator Expressing T Cells Promote Parasitic Growth During Blood Stage
Jogdand GM; Sengupta S; Bhattacharya G; Singh SK; Barik PK; Devadas S
Front Immunol; 2018; 9():1041. PubMed ID: 29892278
[TBL] [Abstract][Full Text] [Related]
8. ICOS controls Foxp3(+) regulatory T-cell expansion, maintenance and IL-10 production during helminth infection.
Redpath SA; van der Werf N; Cervera AM; MacDonald AS; Gray D; Maizels RM; Taylor MD
Eur J Immunol; 2013 Mar; 43(3):705-15. PubMed ID: 23319295
[TBL] [Abstract][Full Text] [Related]
9. Cooperation between 4-1BB and ICOS in the immune response to influenza virus revealed by studies of CD28/ICOS-deficient mice.
Vidric M; Suh WK; Dianzani U; Mak TW; Watts TH
J Immunol; 2005 Dec; 175(11):7288-96. PubMed ID: 16301634
[TBL] [Abstract][Full Text] [Related]
10. ICOS mediates the generation and function of CD4+CD25+Foxp3+ regulatory T cells conveying respiratory tolerance.
Busse M; Krech M; Meyer-Bahlburg A; Hennig C; Hansen G
J Immunol; 2012 Aug; 189(4):1975-82. PubMed ID: 22815292
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary sarcoidosis is associated with high-level inducible co-stimulator (ICOS) expression on lung regulatory T cells--possible implications for the ICOS/ICOS-ligand axis in disease course and resolution.
Sakthivel P; Grunewald J; Eklund A; Bruder D; Wahlström J
Clin Exp Immunol; 2016 Feb; 183(2):294-306. PubMed ID: 26415669
[TBL] [Abstract][Full Text] [Related]
12. Inducible T-Cell Costimulator Mediates Lymphocyte/Macrophage Interactions During Liver Repair.
Ramavath NN; Gadipudi LL; Provera A; Gigliotti LC; Boggio E; Bozzola C; Albano E; Dianzani U; Sutti S
Front Immunol; 2021; 12():786680. PubMed ID: 34925367
[TBL] [Abstract][Full Text] [Related]
13. Cutting Edge: ICOS-Deficient Regulatory T Cells Display Normal Induction of
Landuyt AE; Klocke BJ; Colvin TB; Schoeb TR; Maynard CL
J Immunol; 2019 Feb; 202(4):1039-1044. PubMed ID: 30642977
[TBL] [Abstract][Full Text] [Related]
14. Inducible Costimulator Contributes to Methicillin-Resistant Staphylococcus aureus Pneumonia.
Pires S; Jacquet R; Parker D
J Infect Dis; 2018 Jul; 218(4):659-668. PubMed ID: 29378030
[TBL] [Abstract][Full Text] [Related]
15. ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40-Mediated Tumor Rejection.
Metzger TC; Long H; Potluri S; Pertel T; Bailey-Bucktrout SL; Lin JC; Fu T; Sharma P; Allison JP; Feldman RM
Cancer Res; 2016 Jul; 76(13):3684-9. PubMed ID: 27197182
[TBL] [Abstract][Full Text] [Related]
16. Polygalasaponin F treats mice with pneumonia induced by influenza virus.
Ye Y; Wang H; Liu J; Zhao F; Xu P
Inflammopharmacology; 2020 Feb; 28(1):299-310. PubMed ID: 31446589
[TBL] [Abstract][Full Text] [Related]
17. PC61 (anti-CD25) treatment inhibits influenza A virus-expanded regulatory T cells and severe lung pathology during a subsequent heterologous lymphocytic choriomeningitis virus infection.
Kraft AR; Wlodarczyk MF; Kenney LL; Selin LK
J Virol; 2013 Dec; 87(23):12636-47. PubMed ID: 24049180
[TBL] [Abstract][Full Text] [Related]
18.
Elfaki Y; Yang J; Boehme J; Schultz K; Bruder D; Falk CS; Huehn J; Floess S
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299148
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of inducible costimulator/B7-related protein-1 as a therapeutic target in a murine model of allergic airway inflammation.
Wiley RE; Goncharova S; Shea T; Johnson JR; Coyle AJ; Jordana M
Am J Respir Cell Mol Biol; 2003 Jun; 28(6):722-30. PubMed ID: 12760969
[TBL] [Abstract][Full Text] [Related]
20. An Antibody Targeting ICOS Increases Intratumoral Cytotoxic to Regulatory T-cell Ratio and Induces Tumor Regression.
Sainson RCA; Thotakura AK; Kosmac M; Borhis G; Parveen N; Kimber R; Carvalho J; Henderson SJ; Pryke KL; Okell T; O'Leary S; Ball S; Van Krinks C; Gamand L; Taggart E; Pring EJ; Ali H; Craig H; Wong VWY; Liang Q; Rowlands RJ; Lecointre M; Campbell J; Kirby I; Melvin D; Germaschewski V; Oelmann E; Quaratino S; McCourt M
Cancer Immunol Res; 2020 Dec; 8(12):1568-1582. PubMed ID: 32999002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]